Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
ModernaModerna(US:MRNA) Reuters·2026-03-04 21:26

公司股价与事件影响 - Moderna股价在周三盘前交易中上涨了10% [1] - 此次上涨的直接原因是公司解决了一项长期的法律纠纷 [1] 公司业务与法律进展 - 该法律纠纷涉及使其COVID-19疫苗得以实现的技术 [1] - 该纠纷的解决消除了公司面临的一个不确定性因素 [1]

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang - Reportify